Home> Products> tumor lysis syndrome

{ "products": [ { "_id": "69d389bf4f6df2ce02d84218", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Fenofibrate 160mg", "description": "FENOFIBRON 160 is a clinically trusted lipid-lowering medication formulated with Fenofibrate 160 mg. It is primarily prescribed to manage abnormal cholesterol and triglyceride levels in the body. This medicine plays a vital role in reducing cardiovascular risk and improving overall heart health.\n\nIn today’s fast-paced lifestyle, conditions like high cholesterol and triglycerides are becoming increasingly common due to unhealthy diets, lack of exercise, and stress. FENOFIBRON 160 is an effective solution designed to help regulate lipid levels and prevent serious health complications such as heart disease and stroke.\n\nHow FENOFIBRON 160 Works\n\nFenofibrate belongs to a class of medications known as fibrates. It works by activating a receptor called PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha), which helps regulate lipid metabolism.\n\nThrough this mechanism, FENOFIBRON 160:\n\nReduces triglyceride levels in the blood\nLowers “bad” LDL cholesterol\nIncreases “good” HDL cholesterol\n\nThis balanced lipid control helps reduce plaque formation in the arteries, improves blood flow, and reduces cardiovascular risk.\n\nUses of FENOFIBRON 160\n\nFENOFIBRON 160 is widely prescribed for managing various lipid disorders, including:\n\n1. Hypertriglyceridemia\n\nIt effectively lowers high triglyceride levels, reducing the risk of pancreatitis and heart disease.\n\n2. Mixed Dyslipidemia\n\nUsed to treat patients with a combination of high cholesterol and triglycerides.\n\n3. Hypercholesterolemia\n\nHelps reduce elevated LDL cholesterol levels when lifestyle changes alone are insufficient.\n\n4. Cardiovascular Risk Reduction\n\nSupports prevention of heart-related complications, especially in patients with metabolic syndrome or diabetes.\n\n5. Support in Lifestyle Management\n\nOften prescribed alongside diet and exercise for comprehensive lipid control.\n\nKey Benefits of FENOFIBRON 160\n1. Powerful Triglyceride Reduction\n\nFenofibrate is highly effective in lowering triglyceride levels, which are a major risk factor for heart disease.\n\n2. Improves Good Cholesterol (HDL)\n\nIt boosts HDL cholesterol, helping protect the heart and blood vessels.\n\n3. Reduces Bad Cholesterol (LDL)\n\nHelps in lowering LDL levels, preventing plaque buildup in arteries.\n\n4. Supports Heart Health\n\nBy improving lipid balance, FENOFIBRON 160 reduces the risk of heart attack and stroke.\n\n5. Well-Tolerated Medication\n\nMost patients tolerate fenofibrate well with minimal side effects when taken as prescribed.\n\n6. Convenient Once-Daily Dosage\n\nEnhances patient compliance and long-term treatment success.\n\nDosage and Administration\nFENOFIBRON 160 should be taken as prescribed by a healthcare professional.\nTypically taken once daily with food to enhance absorption.\nSwallow the tablet whole with water.\nDo not crush or chew the tablet.\nContinue taking the medication even if symptoms are not visible, as lipid disorders are often silent.\nPossible Side Effects of FENOFIBRON 160\n\nLike all medications, FENOFIBRON 160 may cause some side effects, although not everyone experiences them.\n\nCommon Side Effects\nHeadache\nNausea\nAbdominal pain\nBack pain\nLess Common Side Effects\nElevated liver enzymes\nMuscle pain or weakness\nDigestive disturbances\nRare but Serious Side Effects\nSevere muscle damage (myopathy or rhabdomyolysis)\nLiver dysfunction\nGallstones\n\nImmediate medical attention is required if severe symptoms occur.\n\nPrecautions and Warnings\nLiver and Kidney Health: Patients with liver or kidney disease should use this medication cautiously.\nAlcohol Consumption: Limit alcohol intake as it may increase the risk of liver damage.\nDrug Interactions: Inform your doctor about other medications, especially statins or blood thinners.\nPregnancy & Breastfeeding: Use only if prescribed by a doctor.\nLifestyle Tips for Better Results\n\nTo maximize the benefits of FENOFIBRON 160:\n\nFollow a low-fat, heart-healthy diet\nExercise regularly\nAvoid smoking\nMaintain a healthy weight\n\nThese lifestyle changes significantly enhance the effectiveness of the medication.\n\nWhy Choose FENOFIBRON 160?\n\nFENOFIBRON 160 stands out as a preferred lipid-lowering solution because of:\n\nHigh-quality formulation\nClinically proven results\nReliable safety profile\nEffective triglyceride and cholesterol management\n\nIt is an excellent choice for patients and healthcare providers aiming for comprehensive lipid control.\n\nConclusion\n\nFENOFIBRON 160 (Fenofibrate 160 mg) is a powerful and reliable medication for managing high triglycerides and cholesterol levels. Its ability to improve lipid balance, support heart health, and reduce the risk of serious cardiovascular complications makes it an essential part of modern treatment strategies.\n\nWhen combined with a healthy lifestyle and taken under proper medical supervision, FENOFIBRON 160 can significantly improve long-term health outcomes. However, adherence to prescribed dosage and regular monitoring are crucial to ensure safety and effectiveness.", "price": 113.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2367, "imageuri": "https://productimages.withfloats.com/actual/69d38a6c102264aa1f048f07.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d38a6c102264aa1f048f07.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-06T10:23:59.089Z", "updatedon": "2026-04-06T10:26:52.122Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fenofibrate-160mg/2367", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FENOFIBRON 160", "category": "CARDIOLOGYRANGE", "tags": [ "Fenofibrate 160mg", "fenofibrate 160mg tab", "fenofibrate 160mg price", "fenofibrate 160mg tablets", "tab fenofibrate 160mg", "tab fenofibrate 160mg uses", "160 mg fenofibrate dosage", "fenofibrate 160 mg uses in hindi", "fenofibrate 160 mg side effects in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695b65af2800555f6696a6cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinacalcet 60 mg Tablet", "description": "CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets\nProduct Overview\nCINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body.\nThe 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet.\nUnderstanding How CINASELECT 60 Works\nCINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream.\nWhen you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH).\nBy lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders.\nPrimary Therapeutic Uses\nSecondary Hyperparathyroidism in Chronic Kidney Disease\nThe primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk.\nCINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues.\nHypercalcemia in Parathyroid Carcinoma\nCINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms.\nPrimary Hyperparathyroidism\nFor patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications.\nKey Benefits of CINASELECT 60\nEffective PTH Control\nClinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification.\nImproved Calcium-Phosphorus Balance\nBy reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life.\nReduced Cardiovascular Risk\nElevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients.\nBone Health Preservation\nUncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density.\nAlternative to Surgery\nFor patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky.\nQuality of Life Improvement\nBy controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity.\nConvenient Oral Administration\nCINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients.\nPotential Side Effects and Adverse Reactions\nCommon Side Effects\nPatients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication.\nDiarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue).\nSerious Side Effects Requiring Medical Attention\nHypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities.\nGastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk.\nAdynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels.\nCardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease.\nAllergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported.\nPrecautions and Contraindications\nCINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH.\nPregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment.\nDosage and Administration Guidelines\nCINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided.\nThe typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved.\nDose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response.\nMonitoring Requirements\nPatients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy.\nAdditionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation.\nStorage and Handling\nCINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package.\nConclusion\nCINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications.\nThe benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management.\nHowever, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2266, "imageuri": "https://productimages.withfloats.com/actual/695b65ebf30763183f64d4f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695b65ebf30763183f64d4f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T07:18:07.264Z", "updatedon": "2026-05-01T06:30:26.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinacalcet-60-mg-tablet/2266", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CINASELECT 60", "category": "NEPHROLOGYRANGE", "tags": [ "cinacalcet 60 mg", "cinacalcet mechanism of action.", "cinacalcet uses", "tab cinacalcet.", "cinacalcet dose.", "cinacalcet structure.", "cinacalcet tab.", "calcium and phosphorus levels in the bloodstream.", "parathyroid hormone secretion.", "calcium metabolism disorders.", "chronic kidney disease and parathyroid conditions.", "cinacalcet 60 mg", "cinacalcet 60", "Cinacalcet Tablets 60 mg price in India", "Buy Cinacalcet Tablets 60 mg online", "Cinacalcet 60 mg wholesale price", "Buy Cinacalcet Tablets 60 mg", "Get Cinacalcet Tablets 60 mg at best price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69299814dd213181136f04b2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin and Clopidogrel Capsules", "description": "Rosuvastatin and Clopidogrel Capsules is a potent combination medication designed to manage and prevent cardiovascular diseases by targeting two critical factors: cholesterol levels and blood clot formation. This combination is particularly recommended for patients at high risk of heart attacks, strokes, or those with existing cardiovascular conditions. By integrating the lipid-lowering benefits of rosuvastatin with the antiplatelet action of clopidogrel, these capsules provide a dual mechanism of action aimed at improving cardiovascular health and reducing potentially life-threatening events.\n\nUses:\nRosuvastatin and Clopidogrel Capsules are primarily used for:\n\nControlling high cholesterol levels, especially reducing low-density lipoprotein (LDL) and triglycerides while increasing high-density lipoprotein (HDL).\n\nPreventing blood clot formation (thrombosis) by inhibiting platelet aggregation, which significantly lowers the risk of heart attacks and strokes.\n\nSlowing the progression of atherosclerosis (plaque buildup in arteries), helping to maintain open blood vessels for improved blood flow.\n\nManaging conditions like coronary artery disease, peripheral artery disease, and after procedures such as angioplasty or bypass surgery to reduce recurrent cardiovascular events.\n\nKey Benefits:\n\nCombined efficacy in lowering cholesterol and preventing clot-related complications contributes to reduced cardiovascular morbidity and mortality.\n\nImproved blood flow achieved by preventing arterial blockages and promoting vascular health.\n\nStabilization of cholesterol plaques in arteries, reducing their risk of rupture.\n\nProtection against acute coronary syndromes and ischemic stroke.\n\nEnhances long-term cardiovascular outcomes in high-risk patients through a synergistic effect of both drugs.\nConvenient oral capsule form encourages patient adherence to prescribed regimens.\nSide Effects:\nWhile generally well tolerated, Rosuvastatin and Clopidogrel Capsules may cause side effects. Common side effects include headache, dizziness, gastrointestinal disturbances such as nausea or abdominal pain, and muscle aches. Patients might experience fatigue or weakness occasionally.\n\nSerious side effects are less frequent but require immediate medical attention. These include severe muscle pain or tenderness (a sign of rhabdomyolysis), allergic reactions, unusual bleeding or bruising (due to clopidogrel’s blood-thinning effects), liver dysfunction, and signs of an infection such as fever or chills. Regular monitoring of liver function tests, blood counts, and muscle-related symptoms is essential during therapy.\n\nConclusion:\nRosuvastatin and Clopidogrel Capsules serve as a comprehensive therapeutic approach for patients with cardiovascular diseases by simultaneously addressing two major risk factors: elevated cholesterol and thrombus formation. Their combined use reduces the risk of heart attacks, strokes, and other severe cardiovascular events while promoting healthier blood flow and vascular function. Adherence to prescribed dosages and periodic medical evaluations will maximize the benefits while minimizing side effect risks. Always consult healthcare professionals before starting or stopping therapy to ensure safety and effectiveness.", "price": 173.0, "discountamount": 52.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2223, "imageuri": "https://productimages.withfloats.com/actual/6929981653223ab539492563.png", "tileimageuri": "https://productimages.withfloats.com/tile/6929981653223ab539492563.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-28T12:39:48.689Z", "updatedon": "2026-03-14T08:11:22.327Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rosuvastatin-and-clopidogrel-capsules/2223", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROUSTRIN CV 10", "category": "cardiology", "tags": [ "Rosuvastatin and Clopidogrel Capsules", "cardiovascular diseases", "heart attacks", "cardiovascular conditions", "heart attacks strokes.", "clopidogrel.", "cholesterol levels and blood clot formation.", "Rosuvastatin and Clopidogrel Capsules." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6815f503b631af66ff8479d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATOVASTRIN EZ F", "description": "ATOVASTRIN EZ F is a scientifically formulated triple-action lipid-lowering medication designed for the comprehensive management of dyslipidemia and mixed hyperlipidemia. Combining Atorvastatin, Fenofibrate, and Ezetimibe, this powerful therapy targets multiple pathways of cholesterol and triglyceride metabolism. It is ideal for patients with elevated LDL cholesterol, triglycerides, and low HDL levels, helping reduce cardiovascular risk effectively.\n\nKey Ingredients\nAtorvastatin Calcium (10 mg):\nA statin that inhibits HMG-CoA reductase, reducing cholesterol production in the liver and lowering LDL (bad cholesterol) and total cholesterol levels.\n\nFenofibrate (160 mg):\nA fibrate that activates peroxisome proliferator-activated receptors (PPAR-alpha) to enhance the breakdown of triglycerides and increase HDL (good cholesterol) levels.\n\nEzetimibe IP (10 mg):\nA cholesterol absorption inhibitor that works at the intestinal level to block the absorption of cholesterol from food, further lowering blood cholesterol.\n\nKey Benefits\nComprehensive control of LDL, HDL, and triglyceride levels\n\nReduces total cholesterol and prevents the buildup of arterial plaque\n\nImproves cardiovascular outcomes in patients at high risk\n\nTargets cholesterol absorption, production, and clearance simultaneously\n\nBeneficial for patients with mixed dyslipidemia, metabolic syndrome, or diabetic dyslipidemia\n\nSupports long-term heart and blood vessel health\n\nHow Does It Work?\nATOVASTRIN EZ F works through a three-pronged mechanism to lower lipid levels:\n\nAtorvastatin blocks HMG-CoA reductase in the liver, reducing cholesterol synthesis and increasing LDL receptor activity to clear more cholesterol from the bloodstream.\n\nFenofibrate stimulates enzymes that enhance the oxidation of fatty acids and reduce triglyceride levels while increasing HDL.\n\nEzetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein in the intestine, preventing dietary and biliary cholesterol absorption.\n\nTogether, these actions reduce LDL cholesterol, raise HDL, and lower triglycerides, offering complete lipid management.\n\nDirections for Use\nTake ATOVASTRIN EZ F exactly as prescribed by your physician.\n\nTypically, one tablet is taken once daily, preferably with or after a meal.\n\nSwallow the tablet whole with water — do not crush or chew.\n\nMaintain a low-fat, heart-healthy diet and follow regular exercise for best results.\n\nRegular monitoring of lipid profile, liver function, and renal function is advised during long-term use.\n\nDo not discontinue the medication without consulting your doctor.\n\nSide Effects\nLike all medications, ATOVASTRIN EZ F may cause some side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nMuscle pain or cramps\n\nDigestive disturbances (nausea, diarrhea, indigestion)\n\nFatigue\n\nMild elevation in liver enzymes\n\nRare but Serious Side Effects:\n\nRhabdomyolysis (muscle breakdown with dark urine and weakness)\n\nLiver toxicity\n\nPancreatitis\n\nGallstones (due to fenofibrate)\n\nAllergic reactions (rash, itching, swelling)\n\nSeek medical help immediately if you experience severe muscle pain, yellowing of eyes/skin, or signs of allergic reaction.", "price": 298.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "allergic reaction", "dark urine", "renal function", "chew maintain", "meal swallow", "daily preferably", "physician typically", "fatty acids", "threepronged mechanism", "ldl hdl", "intestinal level", "comprehensive management", "triglyceride metabolism", "side effects", "atovastrin ez", "biliary cholesterol absorption", "cholesterol absorption inhibitor", "liver enzymes rare", "doctor side effects", "medications atovastrin ez", "work atovastrin ez", "reduce triglyceride levels", "results regular monitoring", "follow regular exercise", "lowfat hearthealthy diet", "intestine preventing dietary", "blood vessel health", "clearance simultaneously beneficial" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2100, "imageuri": "https://productimages.withfloats.com/actual/6815f505a654de67a62eb05a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6815f505a654de67a62eb05a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-03T10:50:43.252Z", "updatedon": "2026-03-16T07:47:50.583Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//atovastrin-ez-f/2100", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Atrovastatin Calcium (10mg), Fenofibrate (160mg), Ezetimibe IP (10mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Atorvastatin 10 mg and Fenofibrate 160 mg Tablet uses", "Atorvastatin 10 mg fenofibrate 160 mg side effects", "Atorvastatin 10 mg and Fenofibrate 160 mg brands", "Atorvastatin 10 Mg and Fenofibrate 160 mg Uses in Hindi", "Atorvastatin 10 mg and Fenofibrate 160 mg Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e95edb100e1fdc2dd5d6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400 \nImatinib IP 400mg\n Cancer treatment has advanced significantly over the years, and targeted therapies have transformed outcomes for many patients. One such breakthrough medicine is Imatinib IP 400mg, marketed as IMATIFLOW 400. This medication is widely used in the treatment of certain types of cancers and blood disorders by targeting the underlying disease process at the molecular level.\n\nIMATIFLOW 400 is a trusted formulation of Imatinib that offers effective disease control while improving quality of life when used as prescribed under medical supervision.\n\nWhat Is Imatinib IP 400mg?\n\nImatinib IP 400mg belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). Unlike traditional chemotherapy that attacks rapidly dividing cells, Imatinib works by specifically blocking abnormal proteins responsible for cancer cell growth.\n\nIMATIFLOW 400 is primarily prescribed for:\n\nChronic Myeloid Leukemia (CML)\n\nGastrointestinal Stromal Tumors (GIST)\n\nCertain rare blood and bone marrow disorders\n\nBy acting at the root cause of disease, Imatinib IP 400mg has become a cornerstone of modern targeted cancer therapy.\n\nHow IMATIFLOW 400 Works\n\nIMATIFLOW 400 works by inhibiting abnormal tyrosine kinase enzymes that signal cancer cells to grow and multiply uncontrollably.\n\nMechanism of Action:\n\nCancer cells produce abnormal proteins due to genetic mutations\n\nThese proteins send continuous growth signals\n\nImatinib blocks these signals\n\nCancer cell growth slows down or stops\n\nDiseased cells gradually die while healthy cells are largely spared\n\nThis targeted approach makes IMATIFLOW 400 more precise and often better tolerated compared to conventional chemotherapy.\n\nUses of Imatinib IP 400mg (IMATIFLOW 400)\n1. Chronic Myeloid Leukemia (CML)\n\nIMATIFLOW 400 is widely used as a first-line treatment for patients with Philadelphia chromosome-positive CML. It helps control disease progression and allows many patients to live longer, more stable lives.\n\n2. Gastrointestinal Stromal Tumors (GIST)\n\nIn patients with inoperable or metastatic GIST, Imatinib IP 400mg helps shrink tumors and prevent further growth.\n\n3. Acute Lymphoblastic Leukemia (ALL)\n\nIn certain cases of Philadelphia chromosome-positive ALL, IMATIFLOW 400 is used as part of combination therapy.\n\n4. Other Rare Conditions\n\nIMATIFLOW 400 may also be prescribed for:\n\nMyelodysplastic syndromes\n\nHypereosinophilic syndrome\n\nCertain dermatological and hematological disorders\n\nKey Benefits of IMATIFLOW 400\nTargeted Cancer Therapy\n\nIMATIFLOW 400 targets cancer cells at a molecular level, reducing unnecessary damage to healthy cells.\n\nImproved Survival Rates\n\nLong-term studies show that Imatinib significantly improves survival and disease control in CML and GIST patients.\n\nOral Administration\n\nUnlike injectable chemotherapy, IMATIFLOW 400 is taken orally, making treatment more convenient.\n\nBetter Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional cancer therapies.\n\nLong-Term Disease Management\n\nMany patients remain on Imatinib therapy for years with stable disease control.\n\nAdvantages of IMATIFLOW 400 Over Conventional Chemotherapy\n\nSpecific action on cancer-causing proteins\n\nLower toxicity profile\n\nReduced hospital visits\n\nImproved patient compliance\n\nSuitable for long-term treatment\n\nThese advantages make IMATIFLOW 400 a preferred choice in targeted oncology care.\n\nDosage and Administration\n\nThe usual dose of Imatinib IP 400mg is one tablet once daily\n\nShould be taken with food and a full glass of water\n\nDosage may vary depending on disease type, stage, and patient response\n\nAlways follow the oncologist’s instructions strictly\n\nDo not stop or adjust the dose without medical advice, as this may affect treatment outcomes.\n\nSide Effects of Imatinib IP 400mg\n\nLike all medicines, IMATIFLOW 400 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nMuscle cramps\n\nFatigue\n\nHeadache\n\nSwelling around eyes or ankles\n\nMild skin rash\n\nThese side effects are usually manageable and improve as the body adjusts to the medicine.\n\nSerious Side Effects\n\nAlthough uncommon, some patients may experience serious side effects, including:\n\nSevere fluid retention\n\nLiver function abnormalities\n\nLow blood cell counts\n\nSevere skin reactions\n\nHeart-related complications (rare)\n\nImmediate medical attention is required if severe symptoms occur.\n\nPrecautions and Warnings\n\nRegular blood tests are required during treatment\n\nLiver function monitoring is important\n\nInform the doctor about all other medicines being taken\n\nUse with caution in patients with heart or liver disease\n\nNot recommended during pregnancy unless clearly advised\n\nBreastfeeding should be avoided during treatment\n\nDrug Interactions\n\nIMATIFLOW 400 may interact with:\n\nCertain antibiotics\n\nAntifungal medicines\n\nBlood thinners\n\nHerbal supplements like St. John’s Wort\n\nAlways inform your doctor about any medication or supplement you are using.\n\nWho Should Take IMATIFLOW 400?\n\nPatients diagnosed with CML\n\nPatients with GIST\n\nIndividuals prescribed targeted therapy by an oncologist\n\nPatients requiring long-term cancer management\n\nStorage Instructions\n\nStore at room temperature\n\nKeep away from moisture and heat\n\nKeep out of reach of children\n\nDo not use after the expiry date\n\nFrequently Asked Questions\nIs IMATIFLOW 400 chemotherapy?\n\nNo, it is a targeted therapy, not traditional chemotherapy.\n\nHow long should Imatinib IP 400mg be taken?\n\nTreatment duration depends on disease response and medical advice. Some patients take it long-term.\n\nCan IMATIFLOW 400 cure cancer?\n\nIt helps control and manage cancer effectively, and in many cases keeps the disease in remission.\n\nIs IMATIFLOW 400 safe for long-term use?\n\nYes, when monitored regularly under medical supervision.\n\nConclusion\n\nIMATIFLOW 400 (Imatinib IP 400mg) represents a major advancement in cancer treatment through its targeted mechanism of action. By directly blocking the proteins responsible for cancer growth, it offers effective disease control with improved tolerability. When taken correctly and under medical guidance, IMATIFLOW 400 can significantly enhance survival, stability, and quality of life for patients battling chronic and complex cancers.", "price": 1827.0, "discountamount": 549.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "CML", "Call", "GIST", "Email", "400mg", "types", "cancers", "therapy", "WhatsApp", "IMATIFLOW", "medication", "information", "Imatinib IP", "progression", "sterispharma", "sterisonline", "proliferation", "patient outcomes", "cancer cell growth", "healthcare professional", "chronic myeloid leukemia", "specific tyrosine kinases", "gastrointestinal stromal tumors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1532, "imageuri": "https://productimages.withfloats.com/actual/667d2405422dd0be2672303b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2405422dd0be2672303b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T11:05:02.332Z", "updatedon": "2026-03-16T11:55:37.907Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-ip-400mg/1532", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400 ", "category": "Oncology", "tags": [ "imatinib 400 mg uses", "side effects of imatinib 400 mg", "imatinib 400 mg uses in hindi", "imatinib 400 mg price in india", "imatinib ip 400mg tablet", "imatinib ip 400 mg uses", "imatinib 400mg tablet ip", "imatinib ip 400mg price in india", "imatinib 400mg dosage guide", "imatinib ip 400mg side effects", "imatinib 400mg tablet composition", "imatinib ip 400mg for leukemia", "imatinib 400mg for cml treatment", "imatinib ip 400mg medicine", "imatinib 400mg tablet how to use", "imatinib ip 400mg benefits", "imatinib 400mg oral chemotherapy tablet", "imatinib ip 400mg indications", "imatinib 400mg tablet working mechanism", "buy imatinib ip 400mg tablet", "imatinib ip 400mg manufacturer india", "imatinib 400mg tablet supplier", "imatinib ip 400mg pharmaceutical company", "what is imatinib ip 400mg", "imatinib 400mg tablet for cancer", "imatinib ip 400mg mechanism of action", "imatinib 400mg tablet side effects in patients", "imatinib ip 400mg treatment duration" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662e4df2bed1f08484d7249", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Enzalutamide 160 mg Tablet", "description": "ENZULAMIDE 160\nEnzalutamide 160mg capsules represent a breakthrough in targeted therapy for advanced prostate cancer, specifically designed to inhibit androgen receptor signaling at multiple levels, slowing cancer progression even in castration-resistant cases. This oral medication, typically taken as a single daily 160mg dose (four 40mg capsules), binds directly to the androgen receptor, preventing nuclear translocation and DNA binding, which starves hormone-dependent prostate tumors of growth signals. Patients with metastatic castration-resistant prostate cancer (mCRPC), non-metastatic CRPC (nmCRPC), or metastatic castration-sensitive prostate cancer (mCSPC) benefit from its ability to delay disease advancement, reduce PSA levels, and extend progression-free survival.​\n\nAdministered continuously without cycling, enzalutamide 160mg maintains steady-state plasma levels for consistent anti-tumor activity, making it suitable for long-term management alongside standard care. Its role expands beyond initial hormone therapy failures, offering hope where traditional options falter.​\n\nProduct Uses: Targeting Advanced Prostate Cancer\nEnzalutamide 160mg primarily treats metastatic castration-resistant prostate cancer (mCRPC) post-chemotherapy or in pre-chemo settings, where tumors grow despite low testosterone. It excels in non-metastatic CRPC (nmCRPC) by delaying metastasis onset, with trials showing median metastasis-free survival exceeding 3 years versus placebo. In mCSPC, combination with ADT prolongs overall survival by months, reducing radiographic progression risks.​\n\nClinicians prescribe it for high-risk patients with rising PSA despite androgen deprivation therapy (ADT), as it shrinks tumors, alleviates bone pain from metastases, and improves quality of life metrics like urinary function and fatigue scores. Regular monitoring via PSA doubling time and imaging guides ongoing use.​\n\nKey Benefits of Enzalutamide 160mg\nEnzalutamide 160mg delivers transformative outcomes through potent androgen blockade:\n\nExtended Progression-Free Survival: PROSPER trial data indicate 97% risk reduction in metastasis or death for nmCRPC; ENZAMET shows 33% overall survival benefit in mCSPC.​\n\nPSA Response Rates: Over 78% achieve ≥50% PSA decline in mCRPC, correlating with radiographic stability and symptom palliation.​\n\nBone Metastasis Control: Lowers skeletal-related events by 30-40%, preserving mobility and reducing fracture incidence when paired with bone agents.​\n\nQuality of Life Preservation: FACT-P scores improve in pain, appetite, and emotional well-being domains, enabling patients to maintain daily activities longer.​\n\nOral Convenience: Once-daily dosing without food restrictions enhances adherence compared to infusions or multi-pill regimens.​\n\nThese advantages position enzalutamide 160mg as a cornerstone in modern prostate cancer protocols, particularly for fit patients tolerating its profile.​\n\nSide Effects: Managing Risks Effectively\nWhile effective, enzalutamide 160mg carries side effects from androgen suppression and receptor antagonism, affecting 70-90% of users to varying degrees. Most prove manageable with supportive care, dose holds, or adjustments, but vigilance remains essential.​\n\nCommon Side Effects\nFrequently reported (≥10%) issues include:\n\nFatigue/Asthenia (30-40%): Profound tiredness impacting daily tasks; rest, exercise, and stimulants like modafinil help.​\n\nHot Flashes (20-25%): Sudden heat waves; cooling strategies and SSRIs alleviate symptoms.​\n\nMusculoskeletal Pain (15-30%): Joint/muscle aches; NSAIDs or physical therapy provide relief.​\n\nDiarrhea/Constipation (10-20%): Alternating bowel changes; fiber, hydration, and laxatives balance gut function.​\n\nHypertension (10-15%): Blood pressure elevations; routine monitoring and antihypertensives control spikes.​\n\nThese transient effects often peak in first months, diminishing with acclimation.​\n\nSerious Side Effects\nSeek immediate care for:\n\nSeizures (1-2%): Risk higher with brain history; anticonvulsants or discontinuation advised.​\n\nFalls/Fractures (10-15%): Due to weakness, dizziness; fall precautions and bone density scans mitigate.​\n\nCardiovascular Events: Myocardial infarction, strokes (2-5%); lipid/BP checks essential.​\n\nPosterior Reversible Encephalopathy Syndrome (PRES): Rare confusion, seizures, vision loss; MRI confirms.​\n\nSevere Skin Reactions: Stevens-Johnson syndrome; rash monitoring critical.​\n\nBaseline neurological assessments and quarterly labs optimize safety.​\n\nDosage and Administration Guidelines\nSwallow four 40mg capsules whole once daily at the same time, with or without food, totaling 160mg. No dose reductions below 120mg recommended; hold for grade 3-4 toxicity, resuming at prior dose once resolved. Hepatic impairment (Child-Pugh B/C) warrants caution; renal adjustments unnecessary. Continue indefinitely unless progression or intolerance occurs.​\n\nPrecautions and Monitoring\nAvoid in seizure history without prophylaxis; women (especially pregnant) must not handle due to teratogenicity. Strong CYP2A4 inducers/inhibitors alter exposure—adjust accordingly. Elderly patients face amplified fall risks; annual DEXA scans track bone health. Regular PSA, testosterone, CBC, liver enzymes, and ECGs ensure proactive management.​\n\nConclusion\nEnzalutamide 160mg stands as a pivotal advancement in prostate cancer care, offering substantial delays in disease progression, symptom control, and survival gains for patients facing hormone-resistant stages. By meticulously balancing its robust benefits against manageable side effects through vigilant monitoring and supportive measures, individuals regain control over their health journey. Consult oncologists to integrate this therapy seamlessly, tailoring it to personal profiles for optimal, life-extending results\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\n\n\n\n\n\n\n\n", "price": 5531.0, "discountamount": 1660.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "mCRPC", "growth", "doctor", "Dosage", "action", "fatigue", "product", "WhatsApp", "patients", "androgens", "ENZULAMIDE", "hot flashes", "information", "Enzalutamide", "sterisonline", "sterispharma", "cancer cells", "hypertension", "male hormones", "administration", "health condition", "Common side effects", "comprehensive advice", "healthcare professional", "potent anti-androgen medication", "metastatic castration-resistant prostate cancer" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1528, "imageuri": "https://productimages.withfloats.com/actual/667d2980c303c6d6ad1360bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2980c303c6d6ad1360bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T10:45:51.202Z", "updatedon": "2026-03-12T07:58:25.307Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//enzalutamide-160-mg-tablet/1528", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ENZULAMIDE 160", "category": "Oncology", "tags": [ "enzalutamide 160 mg price in india", "enzalutamide 160 mg uses", "", "enzalutamide 160 mg side effects", "prostate cancer", "prostate tumors of growth signals", "metastatic castration-resistant prostate cancer", "enzalutamide 160 mg tablet uses", "enzalutamide 160 mg tablet dosage", "enzalutamide 160 mg tablet price in india", "enzalutamide 160 mg tablet composition", "enzalutamide 160 mg tablet benefits", "enzalutamide 160 mg tablet side effects", "enzalutamide 160 mg tablet how it works", "enzalutamide 160 mg tablet mechanism of action", "enzalutamide tablets 160 mg information", "enzalutamide 160 mg tablet cost", "enzalutamide 160 mg tablet supplier india", "enzalutamide 160 mg tablet manufacturer", "enzalutamide 160 mg tablet wholesale price", "enzalutamide 160 mg tablet availability in india", "what is enzalutamide 160 mg tablet", "enzalutamide 160 mg tablet treatment use", "enzalutamide 160 mg tablet precautions", "enzalutamide 160 mg tablet alternatives", "enzalutamide 160 mg tablet substitute", "enzalutamide 160 mg tablet india", "enzalutamide 160 mg tablet near me", "enzalutamide 160 mg tablet online india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662b286db9fdd21801f040b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LENALIMIDE 25", "description": "LENALIMIDE 25\nLenalidomide (25mg)\nLenalidomide 25mg is a medication primarily used to treat certain types of cancers, such as multiple myeloma and myelodysplastic syndromes (MDS). It belongs to a class of drugs known as immunomodulators, which work by affecting the immune system and helping the body fight cancer cells.\n\nThis medicine comes in the form of oral capsules, each containing 25mg of lenalidomide. It is usually taken once daily with water, either with or without food, as directed by your doctor.\n\nLenalidomide works by inhibiting the growth of cancer cells and reducing the formation of new blood vessels in tumors. This can help slow down or stop the progression of cancer.\n\nCommon side effects of lenalidomide may include nausea, diarrhea, constipation, dizziness, fatigue, and low blood cell counts (anemia, neutropenia, thrombocytopenia). It's important to report any severe or persistent side effects to your healthcare provider.\n\nBefore taking lenalidomide, inform your doctor about any other medications you are taking, as well as any medical conditions you have, especially if you are pregnant or planning to become pregnant, as lenalidomide can cause birth defects.\n\nOverall, lenalidomide 25mg is a valuable treatment option for certain cancers and should be used under the supervision of a qualified healthcare professional.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/lenalimide-25-133663\n\n\n\n\n\n\n\n", "price": 3100.0, "discountamount": 930.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDS", "form", "body", "food", "water", "class", "Order", "types", "Email", "drugs", "tumors", "nausea", "growth", "anemia", "severe", "doctor", "fatigue", "cancers", "medicine", "WhatsApp", "diarrhea", "dizziness", "LENALIMIDE", "supervision", "neutropenia", "progression", "constipation", "sterispharma", "sterisonline", "cancer cells", "birth defects", "oral capsules", "immune system", "multiple myeloma", "thrombocytopenia", "immunomodulators", "new blood vessels", "Lenalidomide 25mg", "other medications", "medical conditions", "healthcare provider", "Common side effects", "low blood cell counts", "persistent side effects", "valuable treatment option", "myelodysplastic syndromes", "qualified healthcare professional" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1500, "imageuri": "https://productimages.withfloats.com/actual/667d4a8d1657b0caada580a8.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d4a8d1657b0caada580a8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:11:02.191Z", "updatedon": "2026-03-12T12:25:07.081Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//lenalimide-25/1500", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LENALIMIDE 25", "category": "NEPHROLOGYRANGE", "tags": [ "lenalidomide 25 mg price in india", "lenalidomide 25 mg dose", "lenalidomide side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }